Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma

Published:2014 Issue:2 Volume:18 Page:48
ISSN:1738-6349
Container-title:Korean Journal of Hepato-Biliary-Pancreatic Surgery
language:en
Short-container-title:Korean J Hepatobiliary Pancreat Surg

Author:

Kang Sung-Hwa¹,Hwang Shin¹,Ha Tae-Yong¹,Song Gi-Won¹,Jung Dong-Hwan¹,Kim Ki-Hun¹,Ahn Chul-Soo¹,Moon Deok-Bog¹,Park Gil-Chun¹,Jung Bo-Hyun¹,Yoon Young-In¹,Lee Sung-Gyu¹

Affiliation:

1. Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Publisher

The Korean Association of Hepato-Biliary-Pancreatic Surgery

Subject

General Arts and Humanities

Link

https://synapse.koreamed.org/pdf/10.14701/kjhbps.2014.18.2.48

Reference24 articles.

1. Toward 300 liver transplants a year

2. An Increase in Deceased Donor Incidence Alleviated the Need for Urgent Adult Living Donor Liver Transplantation in a Korean High-Volume Center

3. Living Donor Liver Transplantation for Hepatocellular Carcinoma: Current Status in Korea

4. A clinical assessment of mycophenolate drug monitoring after liver transplantation

5. The long-term liver graft and protocol biopsy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven-year survival after peritoneal metastasis of hepatocellular carcinoma occurring 12 years after living donor liver transplantation;Annals of Liver Transplantation;2023-05-18

2. Drug‐level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients;Transplant Infectious Disease;2022-07-20

3. Absence of association between pretransplant serum soluble programmed death protein-1 level and prognosis following living donor liver transplantation in patients with hepatocellular carcinoma;Medicine;2021-04-30

4. Cross-sectional analysis of immunosuppressive regimens focused on everolimus after liver transplantation in a Korean high-volume transplantation center;Korean Journal of Transplantation;2019

5. Clinical Features and Surveillance of Very Late Hepatocellular Carcinoma Recurrence After Liver Transplantation;Annals of Transplantation;2018-09-21